Solid dosage forms are the core foundation of the drug delivery system. They offer convenient administration, precise dosage, and high cost-effectiveness, making them widely favored by patients and healthcare providers. However, the effectiveness of solid dosage forms is not solely dependent on their active pharmaceutical ingredients (APIs). The drug excipients that are formulated together with the active ingredients play a crucial role in the process of preparing efficient, stable, and user-friendly drugs.
Excipients are not merely simple fillers or inactive auxiliary ingredients; they can enhance therapeutic effects, regulate the rate of drug release, ensure drug stability, and improve the palatability of the drug. In the pharmaceutical process, the role of excipients is of vital importance, directly influencing the overall performance of the product and its market acceptance.
Furthermore, with the continuous advancement in drug research and development, the role of excipients has become increasingly complex and crucial. The innovation in excipient technology has opened up new avenues for solving formulation problems faced by new and highly effective active pharmaceutical ingredients (APIs). The journey of the pharmaceutical industry towards more advanced drug delivery mechanisms further highlights the indispensable importance of excipients.

In recent years, the pharmaceutical excipients industry has witnessed significant technological advancements, which are primarily aimed at enhancing the technical capabilities of drug formulations and addressing specific challenges related to the delivery of active pharmaceutical ingredients (APIs). These innovations are crucial for improving the efficacy, safety, and patient compliance with medications, thereby playing a key role in the successful launch of pharmaceutical products.
One of the most pressing issues in drug development is that many new chemical compounds have poor water solubility. Chandan Kaiwar, the product manager of Kerry Company, provided the following examples to illustrate how excipients can help improve the solubility and bioavailability of drugs:
Solubilization: Surfactants and co-solvents as auxiliary materials form micelles or enhance the solubility of drug molecules to increase the solubility of the drug.
Particle size reduction: Auxiliary materials such as polymers or surfactants can reduce the particle size of the drug, thereby increasing the surface area available for dissolution and absorption.
Complexation: Auxiliary materials such as cyclodextrins can form inclusion complexes with poorly soluble drugs, thereby increasing their solubility and dissolution rate.
Amorphous solid dispersion: Auxiliary materials such as polymers can form amorphous solid dispersions, thereby preventing drug crystallization and promoting rapid dissolution.
pH modification: Auxiliary materials such as buffers can change the pH value of the gastrointestinal tract, thereby optimizing the solubility and absorption rate of the drug at a specific site.
The processing of excipients is a significant advancement in pharmaceutical formulation technology. Its design aims to overcome the limitations of traditional excipients, while optimizing the production process and enhancing the performance of the drugs. These composite particles are made through physical processing of two or more excipients, and the properties of the resulting products are superior to those of a simple physical mixture of the individual components.
The main advantage of using co-milled excipients lies in their ability to enhance the functionality of the formulation. These excipients can improve the compressibility of tablets, optimize fluidity, and optimize the dissolution characteristics of the active pharmaceutical ingredient (API). For instance, a co-milled product composed of ultra-slow disintegrants and fillers can achieve a more rapid disintegration rate without reducing the hardness or integrity of the tablet, thereby enhancing the onset time of the API’s effect.

Although the excipient technology has made significant progress in recent years, there are still several challenges that need to be overcome through continuous research and innovation. These challenges cover multiple aspects such as formulation development, production manufacturing, regulatory compliance, and market demand.
Maintaining the formulation stability of the drug within its expiration period is of vital importance for ensuring the efficacy and safety of the product. Excipients can affect the stability of the active pharmaceutical ingredient (API) through various mechanisms, such as degradation reactions, hygroscopic effects, and physical interactions. Formulators must conduct rigorous stability tests to identify potential stability issues and accordingly optimize the composition of the formulation.
The regulatory framework for controlling auxiliary materials is complex and constantly evolving. Regulatory agencies have set strict standards for the quality, safety, and documentation requirements of auxiliary materials. Adhering to relevant regulatory guidelines is a necessary condition for obtaining market approval and achieving commercial production, which further increases the complexity of the formulation and development process.
The cost of auxiliary materials may account for a significant portion of the overall production expenses, especially for high-volume products. Formulators must strike a balance between cost considerations and the demand for high-quality auxiliary materials that meet regulatory standards. Chandan Kaiwar, the product manager of Kerry, shared his insights on the supply chain issues and trends related to the use of auxiliary materials in pharmaceutical production:
Raw material sourcing: Due to geopolitical tensions and market fluctuations, the stability, quality and cost of raw materials are all facing challenges.
Regulatory compliance: There are strict requirements for the production, transportation and storage of auxiliary materials, and they must comply with GMP and international standards.
Quality assurance: Ensure the integrity and purity of the entire supply chain to maintain product safety and quality standards.
Globalization: Due to the global nature of auxiliary material procurement and production, there are complexities in logistics, compliance and quality control.
Supply chain resilience: Focus on building a resilient supply chain system by implementing strategies such as dual procurement and risk mitigation measures, so that it can effectively respond to supply disruptions.
Sustainability: Emphasize sustainable practices, including environmentally friendly processes and renewable resources. This initiative stems from concerns about environmental issues and regulatory pressures.
Excipients play a crucial role in pharmaceutical formulations, directly influencing the safety, efficacy and overall performance of the drugs. Moreover, ensuring the safety and effectiveness of excipients is of utmost importance for the research and development of drugs as well as the regulatory approval process.

Reference: Excipients Used for Solid Dosage: Innovations and Challenges. Tablets & Capsules, June 1, 2024. Available online: https://www.tabletscapsules.com/3641-Technical-Articles/613461-Excipients-Used-for-Solid-Dosage-Innovations-and-Challenges/
HPMC and L-HPC manufacturer
22 years of production and sales experience
CEP-certified products meet FDA and GMP regulations
No.358, Zijing Road, Huzhou, Zhejiang, China 313000
No.88, Zhongde Road, Linghu Town, Huzhou, Zhejiang, China 313000